QT
ESPR

Quantbot Technologies’s Esperion Therapeutics ESPR Stock Holding History

Quantbot Technologies’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-244,292
Closed -$904K – 1828
2025
Q4 		$904K Buy
244,292
+64,653
+36% +$209K 0.03% 711
2025
Q3 		$476K Buy
+179,639
New +$347K 0.01% 1045
2023
Q4 		– Sell
-6,122
Closed -$6K – 1688
2023
Q3 		$6K Sell
6,122
-4,119
-40% -$5.96K ﹤0.01% 1444
2023
Q2 		$14.2K Sell
10,241
-24,180
-70% -$33.8K ﹤0.01% 1441
2023
Q1 		$54.7K Buy
+34,421
New +$178K ﹤0.01% 1234
2022
Q1 		– Sell
-36,904
Closed -$184K – 1751
2021
Q4 		$184K Buy
36,904
+26,995
+272% +$216K 0.01% 752
2021
Q3 		$119K Buy
+9,909
New +$144K 0.01% 921
2020
Q2 		– Sell
-691
Closed -$21K – 1212
2020
Q1 		$21K Buy
+691
New +$36.5K 0.01% 580
2018
Q4 		– Sell
-2,250
Closed -$99K – 1125
2018
Q3 		$99K Buy
+2,250
New +$103K 0.01% 878
2018
Q2 		– Sell
-1,588
Closed -$114K – 1280
2018
Q1 		$114K Buy
1,588
+1,234
+349% +$90.6K 0.01% 814
2017
Q4 		$23K Sell
354
-367
-51% -$19.8K ﹤0.01% 1057
2017
Q3 		$36K Sell
721
-2,132
-75% -$103K ﹤0.01% 999
2017
Q2 		$132K Sell
2,853
-1,640
-37% -$60.3K 0.01% 743
2017
Q1 		$158K Buy
+4,493
New +$103K 0.02% 680
2016
Q1 		– Sell
-3,118
Closed -$69K – 1217
2015
Q4 		$69K Buy
+3,118
New +$78.7K 0.01% 743
2015
Q2 		– Sell
-2,015
Closed -$186K – 1182
2015
Q1 		$186K Buy
+2,015
New +$130K 0.05% 430

Other funds holding ESPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's ESPR Position: Q1 2026 in Review

Quantbot Technologies sold out of Esperion Therapeutics (ESPR) in Q1 2026, closing a stake of 244,292 shares — an estimated $904K sold.

Quantbot Technologies first reported a position in ESPR in Q1 2015 and held it in 16 quarters. The position peaked at $904K in Q4 2025. 207 funds tracked by Wall St. Rank hold ESPR as of Q1 2026.

  • Quantbot Technologies reported no remaining Esperion Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 244,292 Esperion Therapeutics shares in Q1 2026, an estimated $904K.
  • Quantbot Technologies first reported a position in Esperion Therapeutics in Q1 2015 and held it in 16 quarters.
  • Quantbot Technologies's Esperion Therapeutics position peaked at $904K in Q4 2025.
  • 207 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.